Top

Published in:

Open Access 01-12-2016 | Editorial

Non-antibiotic treatments for bacterial diseases in an era of progressive antibiotic resistance

Author: Steven M. Opal

Published in: Critical Care | Issue 1/2016

Abstract

The emergence of multi-drug resistant (MDR) microbial pathogens threatens the very foundation upon which standard antibacterial chemotherapy is based. We must consider non-antibiotic solutions to manage invasive bacterial infections. Transition from antibiotics to non-traditional treatments poses real clinical challenges that will not be easy to solve. Antibiotics will continue to reliably treat some infections (e.g., group A streptococci and Treponema pallidum) but will likely need adjuvant therapies or will need to be replaced for many bacterial infections in the future.

Rolain JM, Parola P, Cornaglia C. New Delhi metallo-beta lactamase (NDM-1): towards a new pandemic? Clin Microbial Infect. 2010;16(12):1699–76.CrossRef

Liu Y-Y, Wang Y, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism, MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16(2):160–8.

McCrea K, Ward R, LaRosa S. Removal of carbapenem-resistant Enterobacteriaceae (CRE) from blood by heparin-functional hemoperfusion media. PLoS One. 2014;9(12), e114242.CrossRefPubMedPubMedCentral

Kang JH, Super M, Yung CW, et al. An extracorporeal blood-cleaning device for sepsis therapy. Nat Med. 2014;20:1211–6.CrossRefPubMed

Brackman G, Coenye T. Quorum sensing inhibitors as anti-biofilm agents. Curr Pharm Des. 2015;21(1):5–11.CrossRefPubMed

Kalia V. Quorum sensing inhibitors: an overview. Biotechnol Adv. 2013;31(2):224–45.CrossRefPubMed

Wright A, Hawkins CH, Anggard EE, Harper DR. A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy. Clin Otolaryngol. 2009;34(4):349–57.CrossRefPubMed

Wittebole X, De Roock S, Opal S. A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens. Virulence. 2014;5(1):226–35.CrossRefPubMed

Irani V, Guy A, Andrew D, et al. Molecular properties of human IgG subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases. Mole Immun. 2015;67:171–82.CrossRef

10.

Lu Q, Rouby JJ, Laterre PF, et al. Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa 011 pneumonia. J Antimicrob Chemother. 2011;66(5):1110–6.CrossRefPubMed

11.

Luke T, Wu H, Zhao J, et al. Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoA in vivo. Sci Transl Med. 2016;8(326):326ra21.CrossRefPubMed

12.

Boomer J, To K, Chang K, et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA. 2011;306(23):2594–605.CrossRefPubMedPubMedCentral

13.

Henry B, Neill D, Becker K, et al. Engineered liposomes sequester bacterial exotoxins and protect from severe invasive infections in mice. Nat Biotechnol. 2015;33(1):81–8.CrossRefPubMed

14.

Medzhitov R, Schneider D, Soares M. Disease tolerance as a strategy. Science. 2012;335(6071):936–14.CrossRefPubMedPubMedCentral

15.

Rassmussen AL, Okumura A, Ferris MT, et al. Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance. Science. 2014;346(6212):987–91.CrossRef

Title: Non-antibiotic treatments for bacterial diseases in an era of progressive antibiotic resistance
Author: Steven M. Opal
Publication date: 01-12-2016
Publisher: BioMed Central
Published in: Critical Care / Issue 1/2016
Electronic ISSN: 1364-8535
DOI: https://doi.org/10.1186/s13054-016-1549-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Non-antibiotic treatments for bacterial diseases in an era of progressive antibiotic resistance

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2016

Reported burden on informal caregivers of ICU survivors: a literature review

Erratum to: Multiple imputation is better than KDIGO guidelines for estimating unknown baseline renal function

From bedside to bench: the missing brick for patients with fungal sepsis

The use of angiotensin II in distributive shock

Communication tools for end-of-life decision-making in the intensive care unit: a systematic review and meta-analysis

Resting energy expenditure, calorie and protein consumption in critically ill patients: a retrospective cohort study